OBCI Past Earnings image   This OBCI past earnings page last updated 9/15/2022
OBCI Past Earnings
PeriodPast Earnings DateGAAP
Q1 20225/16/20220.140
Q4 20213/31/20220.070
Q3 202111/15/20210.340
Q2 20218/16/20210.270
Q1 20215/17/20210.200
Q4 20203/29/20210.090
Q3 202011/13/20200.490
Q2 20208/10/20200.360
Q1 20205/15/20200.070
Q4 20193/30/20200.070
Q3 201911/14/20190.120
Q2 20198/14/20190.110
Q1 20195/15/20190.080
Q4 20183/29/2019-0.01
Q3 201811/14/20180.14
Q2 20188/14/20180.12
Q1 20185/15/20180.06
Q4 20174/2/20180.03
Q3 201711/14/20170.09
Q2 20178/14/20170.1
Q1 20175/15/20170.05
Q4 20163/31/20170.05
Q3 201611/14/20160.17
Q2 20168/15/20160.07
Q1 20165/16/2016-0.06
Q4 20153/31/20160.01
Q3 201511/13/20150.03
Q2 20158/14/20150.01
Q1 20155/15/20150
Q4 20141/15/20150.06
Q3 201411/13/20140.1
Q2 20148/14/20140.05
Q1 20145/15/20140.03
Q4 20133/31/20140.04
Q3 201311/14/20130.07
Q2 20138/14/20130.08
Q1 20135/16/20130.04
Q4 20124/1/20130.07
Q3 201211/14/20120.09
Q2 20128/14/20120.09
OBCI Past Revenue
PeriodPast Earnings DateGAAP
Q1 20225/16/20220.01B
Q4 20213/31/20220.01B
Q3 202111/15/20210.02B
Q2 20218/16/20210.02B
Q1 20215/17/20210.01B
Q4 20203/29/20210.01B
Q3 202011/13/20200.02B
Q2 20208/10/20200.02B
Q1 20205/15/20200.01B
Q4 20193/30/20200.01B
Q3 201911/14/20190.01B
Q2 20198/14/20190.01B
Q1 20195/15/20190.01B
Q4 20183/29/20198.84M
Q3 201811/14/201813.18M
Q2 20188/14/201811.40M
Q1 20185/15/20188.38M
Q4 20174/2/20188.99M
Q3 201711/14/201711.65M
Q2 20178/14/20179.90M
Q1 20175/15/20178.39M
Q4 20163/31/20178.52M
Q3 201611/14/201612.21M
Q2 20168/15/20168.72M
Q1 20165/16/20166.75M
Q4 20153/31/20168.41M
Q3 201511/13/201510.84M
Q2 20158/14/20158.74M
Q1 20155/15/20156.00M
Q4 20141/15/20158.70M
Q3 201411/13/201410.40M
Q2 20148/14/20148.81M
Q1 20145/15/20145.92M
Q4 20133/31/20147.80M
Q3 201311/14/201310.44M
Q2 20138/14/20138.18M
Q1 20135/16/20136.30M
Q4 20124/1/20130.01B
Q3 201211/14/201210.26M
Q2 20128/14/20120.01B
Quotes delayed 20 minutes

Email EnvelopeFree OBCI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ocean Bio-Chem (OBCI) is categorized under the Consumer sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ODC Past Earnings
OSK Past Earnings
OXM Past Earnings
PATK Past Earnings
PCAR Past Earnings
PEP Past Earnings
PETQ Past Earnings
PG Past Earnings
PII Past Earnings
PLBY Past Earnings

OBCI Past Earnings Q&A

What was the best and worst OBCI past earnings results?
For Ocean Bio-Chem, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest OBCI past earnings result in our data set was 0.490/share posted in Q3 2020, while the lowest was in Q1 2016 when OBCI posted -0.06/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q3 2021 when OBCI reported 0.02B in revenue, while the quarter with the lowest revenue in our data set was Q1 2014 at 5.92M of revenue.

  Suggested answer: There are 40 OBCI past earnings results in our data set.

On this page we presented the OBCI past earnings date information for Ocean Bio-Chem. Reviewing that OBCI Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2020, when OBCI posted gaap of 0.490/share. Meanwhile the lowest OBCI past earnings result was in Q1 2016, when OBCI posted gaap of -0.06/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q3 2021 when OBCI reported 0.02B in revenue, while the smallest revenue quarter was Q1 2014 when OBCI reported 5.92M in revenue.

Any self directed investor doing their due diligence on OBCI or any other given stock can benefit from researching all of the Ocean Bio-Chem past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Ocean Bio-Chem past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for OBCI. Thanks for visiting, and the next time you need to research OBCI past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.

Recommended: SLQD Historical Stock Prices, J.B. Hunt Transport Services MACD, Institutional Holders of TYTE.

 

OBCI Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.